Evidence map›Paper›PMID 40298862›Full record

ArticleAntioxidants (Basel, Switzerland)2025

Redox Mechanisms Driving Skin Fibroblast-to-Myofibroblast Differentiation.

Marzieh Aminzadehanboohi, Manousos Makridakis, Delphine Rasti, Yves Cambet, Karl-Heinz Krause, Antonia Vlahou, Vincent Jaquet

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Analysis of the Phenolic Profile ofInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marzieh AminzadehanboohiDepartment of Pathology and Immunology, Medical School, University of Geneva, 1211 Geneva, Switzerland.
Manousos MakridakisCenter of Systems Biology, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece.ORCID 0000-0002-0063-3559
Delphine RastiDepartment of Pathology and Immunology, Medical School, University of Geneva, 1211 Geneva, Switzerland.
Yves CambetREADS Unit, Medical School, University of Geneva, 1211 Geneva, Switzerland.
Karl-Heinz KrauseDepartment of Pathology and Immunology, Medical School, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0002-9033-6768
Antonia VlahouCenter of Systems Biology, Biomedical Research Foundation Academy of Athens, 11527 Athens, Greece.ORCID 0000-0003-3284-5713
Vincent JaquetDepartment of Pathology and Immunology, Medical School, University of Geneva, 1211 Geneva, Switzerland.ORCID 0000-0003-2229-2406

Funding

European Union 278611Swiss National Science Foundation 31003A-179478
6 · The paper itself

Abstract

Transforming Growth Factor-Beta 1 (TGF-β1) plays a pivotal role in the differentiation of fibroblasts into myofibroblasts, which is a critical process in tissue repair, fibrosis, and wound healing. Upon exposure to TGF-β1, fibroblasts acquire a contractile phenotype and secrete collagen and extracellular matrix components. Numerous studies have identified hydrogen peroxide (H

Indexed as

epidermal growth factorfibroblastsmyofibroblastsproteomicsredox signallingthiol oxidationtransforming growth factor β1

Identifiers

PMID40298862
PMCPMC12024386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.